Gene · 1109
Papers1,988
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,988
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alteration in glucocorticoids secretion and metabolism in patients affected by cystic fibrosis. | Front Endocrinol (Lausanne) | 2022 | 36568105 | PubTator, text mining | PubMed |
| Complex Building Forms Roofed with Transformed Shell Units and Defined by Saddle Surfaces. | Materials (Basel) | 2022 | 36556747 | PubTator, text mining | PubMed |
| Single-cell transcriptome reveals core cell populations and androgen-RXFP2 axis involved in deer antler full regeneration. | Cell Regen | 2022 | 36542206 | PubTator, text mining | PubMed |
| Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis? | Can J Gastroenterol Hepatol | 2022 | 36523650 | PubTator, text mining | PubMed |
| The role of Neanderthal introgression in liver cancer. | BMC Med Genomics | 2022 | 36503519 | PubTator, text mining | PubMed |
| Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling. | Nutrients | 2022 | 36500979 | PubTator, text mining | PubMed |
| Gas Permeability Evolution of Coal with Inclusions under Triaxial Compression-Lab Testing and Numerical Simulations. | Materials (Basel) | 2022 | 36500062 | PubTator, text mining | PubMed |
| The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial. | PLoS One | 2022 | 36480560 | PubTator, text mining | PubMed |
| ISG15 Is a Novel Regulator of Lipid Metabolism during Vaccinia Virus Infection. | Microbiol Spectr | 2022 | 36453897 | PubTator, text mining | PubMed |
| Derivation of nociceptive sensory neurons from hiPSCs with early patterning and temporally controlled NEUROG2 overexpression. | Cell Rep Methods | 2022 | 36452863 | PubTator, text mining | PubMed |
| Optimal COVID-19 epidemic strategy with vaccination control and infection prevention measures in Thailand. | Infect Dis Model | 2022 | 36438694 | PubTator, text mining | PubMed |
| Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers. | Diagnostics (Basel) | 2022 | 36428847 | PubTator, text mining | PubMed |
| Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma. | Biomedicines | 2022 | 36428523 | PubTator, text mining | PubMed |
| SIGIRR deficiency contributes to CD4 T cell abnormalities by facilitating the IL1/C/EBPβ/TNF-α signaling axis in rheumatoid arthritis. | Mol Med | 2022 | 36401167 | PubTator, text mining | PubMed |
| Role of Human Aldo-Keto Reductases in the Nitroreduction of 1-Nitropyrene and 1,8-Dinitropyrene. | Chem Res Toxicol | 2022 | 36399404 | PubTator, text mining | PubMed |
| In vitro models for investigating itch. | Front Mol Neurosci | 2022 | 36385768 | PubTator, text mining | PubMed |
| Histochemical Comparison of Human and Rat Lacrimal Glands: Implications for Bio-Engineering Studies. | Transl Vis Sci Technol | 2022 | 36374486 | PubTator, text mining | PubMed |
| Elevated plasma miR-210 expression is associated with atypical genitalia in patients with 46,XY differences in sex development. | Mol Genet Genomic Med | 2022 | 36369742 | PubTator, text mining | PubMed |
| Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine. | Pharmaceutics | 2022 | 36365185 | PubTator, text mining | PubMed |
| Iron: Not Just a Passive Bystander in AITD. | Nutrients | 2022 | 36364944 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1109/papers?page=12